424B4424B4
May 1, 2026Final prospectus0001193125-26-201758
Sources: SEC EDGAR, Nasdaq
Seaport Therapeutics Inc trades publicly. Prices are daily closing quotes.
View on NasdaqIPO Calendar · updated 3h ago
Lock-up schedule, public float and locked shares extracted from Seaport Therapeutics Inc's SEC prospectus. Shares shown are eligible to trade — lock-up expiry does not mean holders have sold or will sell.
Seaport Therapeutics Inc is a clinical-stage biopharmaceutical company developing therapies for cancer and other serious diseases, organized around advancing candidates through preclinical and clinical stages toward regulatory review.
EDGAR filings resolved from SPTX / CIK 0002042347.